Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Eying border reopening, Mexico begins J&J vaccine rollout in Baja California

06/17/2021 | 07:14pm EDT

By Carlos Zuñiga

Tijuana, Mexico, Jun 17 (EFE).- Mexico on Thursday began administering a shipment of 1.35 million Johnson & Johnson Covid-19 vaccines donated by the United States, a rollout in the northwestern state of Baja California that is aimed at reopening a border closed to non-essential travel for the past 15 months.

Baja California - including Tijuana, the country's largest border city with more than 1.9 million inhabitants - became the first Mexican state with vaccines made available universally to all adults 18 or over.

Authorities set up 16 vaccination points in the state's six municipalities - the capital, Mexicali; Tijuana; Ensenada; Playas de Rosarito; Tecate; and San Quintin.

The Health Secretariat's goal is to administer all 1.35 million, single-dose Johnson & Johnson vaccines over a period of 10 days.

Great anticipation surrounded the rollout, with hundreds of people - most of them young adults - waiting in line starting Wednesday night in hopes of being among the first to be inoculated against Covid-19, a disease that is blamed for more than 8,500 deaths in Baja California, one of the hardest-hit Mexican states.

"(Young people) should get vaccinated. It's important to care for your health, and you have to respect the pandemic," 18-year-old Evelin told Efe after being vaccinated in Tijuana.

Mexico's government initially said the first shipment of Johnson & Johnson vaccines that arrived Tuesday from the US would be used to inoculate all adults in the country's 39 northern border muncipalities.

But it was later decided to use them exclusively in Baja California.

"Baja California, at the president's instruction, is the first (territorial) entity that will have universal vaccination of (people) 18 years and older," Mexican security chief Rosa Icela Rodriguez said Thursday during President Andres Manuel Lopez Obrador's regular morning press conference.

With Mexico ranking fourth worldwide in Covid-19 deaths (more than 230,000) and having recorded nearly 2.5 million confirmed coronavirus cases since the start of the pandemic, Lopez Obrador is banking on getting the situation under control with an accelerated vaccine rollout.

Since December, however, Mexico has only administered just over 38 million doses of different vaccines; and only around 15 million Mexicans are fully immunized thus far in a country of 126 million inhabitants.

US Vice President Kamala Harris offered the Johnson & Johnson vaccines to Lopez Obrador, popularly known as AMLO, who pledged to acquire more doses as part of a special program aimed at convincing the US to reopen the countries' shared border to non-essential travel.

"This is a special program because these vaccines have arrived (in Mexico) and we want to vaccinate the population of the 39 border municipalities so the border can be opened as soon as possible," AMLO said Thursday.

Mexican authorities are aiming for a mid-July return to normal at the border, which had $1.7 billion worth of two-way trade and around 1 million legal border crossings per day prior to the pandemic. EFE

© 2021 EFE News Services (U.S.) Inc., source EFE Ingles

All news about JOHNSON & JOHNSON
11:26aJOHNSON & JOHNSON : Single-Shot COVID-19 Vaccinations to Resume in the U.S. for ..
06:06aJOHNSON & JOHNSON : Mozambique to Vaccinate 20 Per Cent of Its Target By Septemb..
07/26ASPEN PHARMACARE : To Send First Batch Of Johnson & Johnson Jab To South Africa ..
07/23Relaxed Border Restrictions For U.S. Travelers Coming August 9, 2021
07/23GLOBAL MARKETS LIVE : Intel, HoneyWell, American Express, Visa, Twitter...
07/23JOHNSON & JOHNSON : UBS Adjusts Johnson & Johnson's Price Target to $183 From $1..
07/23ASTRAZENECA : EU On Track To Donate 200 Million COVID-19 Vaccine Doses In 2021
07/22JOHNSON & JOHNSON : Opioid-ravaged West Virginia looks to $26B deal for help
07/22JOHNSON & JOHNSON : In opioid-ravaged WVa, potential deal raises hopes for help
07/22JOHNSON & JOHNSON : Genmab Announces Net Sales of DARZALEX (daratumumab) for the..
More news
Financials (USD)
Sales 2021 94 447 M - -
Net income 2021 22 808 M - -
Net Debt 2021 871 M - -
P/E ratio 2021 20,2x
Yield 2021 2,40%
Capitalization 453 B 453 B -
EV / Sales 2021 4,80x
EV / Sales 2022 4,59x
Nbr of Employees 134 500
Free-Float 84,3%
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 171,87 $
Average target price 184,35 $
Spread / Average Target 7,26%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON9.21%452 602
ROCHE HOLDING AG11.50%327 852
PFIZER, INC.13.58%234 040
NOVARTIS AG-0.17%221 954
ABBVIE INC.9.93%208 043